NCT01184885 2025-05-04
A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
Thomas Jefferson University
National Cancer Institute (NCI)
Universität des Saarlandes
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AIDS Malignancy Consortium